Cargando…

The β-fibrinogen gene 455G/A polymorphism associated with cardioembolic stroke in atrial fibrillation with low CHA(2)DS(2)-VaSc score

Previous work has suggested that ischemic stroke (IS) may be more likely to occur in individuals with a genetic predisposition. In this study, we investigated the potential association of IS-relevant genetic risk factors with cardioembolic stroke (CES) in atrial fibrillation (AF) patients with low C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Xiaofeng, Wang, Junjun, Li, Yaguo, Wu, Jiong, Qiao, Song, Xu, Shanhu, Huang, Jun, Chen, Linhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727505/ https://www.ncbi.nlm.nih.gov/pubmed/29235504 http://dx.doi.org/10.1038/s41598-017-17537-1

Ejemplares similares

CHA(2)DS(2)-VASc: time to settle the score?
por: Kaplan, Rachel M., et al.
Publicado: (2022)

CHA(2)DS(2)-VASc and R(2)-CHA(2)DS(2)-VASc scores predict in-hospital and post-discharge outcome in patients with myocardial infarction
por: Węgiel, Michał, et al.
Publicado: (2018)

Better prediction of stroke in atrial fibrillation with incorporation of cancer in CHA(2)DS(2)VASC score: CCHA(2)DS(2)VASC score
por: Bungo, Brandon, et al.
Publicado: (2022)

Beyond CHA(2)DS(2)-VASc in atrial fibrillation: the atrium and the risk of stroke
por: Boccanelli, Alessandro
Publicado: (2020)

CHA(2)DS(2)-Vasc score and CHA(2)DS(2)-Vasc-HS score are poor predictors of in-stent restenosis among patients with coronary drug-eluting stents
por: Zhao, Sheng Gang, et al.
Publicado: (2019)

CHA2DS2-VASc score and modified CHA2DS2-VASc score can predict mortality and intensive care unit hospitalization in COVID-19 patients
por: Gunduz, Ramazan, et al.
Publicado: (2021)

Heart failure: a weak link in CHA(2)DS(2)‐VASc
por: Friberg, Leif, et al.
Publicado: (2018)

CHA(2)DS(2)-VASc Score in Cardio-Oncology: Sharpening the Rules
por: López-Fernández, Teresa
Publicado: (2023)

Predictive value of CHA(2)DS(2)-VASc and CHA(2)DS(2)-VASc-HS scores for failed reperfusion after thrombolytic therapy in patients with ST-segment elevation myocardial infarction
por: Kilic, Salih, et al.
Publicado: (2019)

Cheating the CHA(2)DS(2)-VASc Score: Thromboembolism in Apical Hypertrophic Cardiomyopathy
por: Weir, Robin A. P., et al.
Publicado: (2014)

Correlation between CHA(2)DS(2)-VASc Score and Glaucoma Treatment and Prognosis
por: Pikkel, Yoav Y., et al.
Publicado: (2018)

Escore CHA2DS2-VASc: O Que Mais Podemos Predizer?
por: Maia, Adnaldo da Silveira
Publicado: (2023)

High CHA(2)DS(2)-VASc score without atrial fibrillation: ‘NAO yes, NAO no’
por: Perna, Gian Piero
Publicado: (2019)

CHA(2)DS(2)-VASc score stratifies mortality risk in patients with and without atrial fibrillation
por: Harb, Serge C, et al.
Publicado: (2021)

Prognostic Impacts of CHADS(2), CHA(2)DS(2)-VASc, and CHA(2)DS(2)-VASc-HS Scores on Clinical Outcomes After Elective Drug-Eluting Stent Placement for De Novo Coronary Stenosis
por: Ukaji, Tomoaki, et al.
Publicado: (2023)

Value of the CHA(2)DS(2)‐VASc score for predicting outcome in patients with heart failure
por: Shuvy, Mony, et al.
Publicado: (2020)

Does CHA2DS2-VASc score predict mortality in chronic kidney disease?
por: Goudis, Christos, et al.
Publicado: (2021)

Stroke and systemic embolism risk in patients with CHA(2)DS(2)‐VASc score of 0
por: Babayiğit, Erdi, et al.
Publicado: (2023)

Risk factors of thromboembolism in nonvalvular atrial fibrillation patients with low CHA(2)DS(2)-VASc score
por: Yan, Shuangbing, et al.
Publicado: (2019)

The association of CHA(2)DS(2)-VASc score and carotid plaque in patients with non-valvular atrial fibrillation
por: Shang, Luxiang, et al.
Publicado: (2019)

Risk of ischemic stroke and utility of CHA(2)DS(2)‐VASc score in women and men with atrial fibrillation
por: Tomasdottir, Maria, et al.
Publicado: (2019)

The relationship of the serum endocan level with the CHA(2)DS(2)-VASc score in patients with paroxysmal atrial fibrillation
por: Ceyhun, Gökhan
Publicado: (2021)

Association between Gut Microbiota Dysbiosis and the CHA2DS2-VASc Score in Atrial Fibrillation Patients
por: Fang, Chen, et al.
Publicado: (2022)

Changes in CHA(2)DS(2)-VASc score and risk of ischemic stroke among patients with atrial fibrillation
por: Tsiartas, Eirinaios, et al.
Publicado: (2023)

ACC/AHA Hypertension Guidelines and CHA(2)DS(2)-VASc Up-Scoring in Patients With Atrial Fibrillation
por: Pundi, Krishna, et al.
Publicado: (2023)

R(2(GFR))CHADS(2) and R(2(GFR))CHA(2)DS(2)VASc schemes improved the performance of CHADS(2) and CHA(2)DS(2)VASc scores in death risk stratification of Chinese older patients with atrial fibrillation
por: Fu, Shihui, et al.
Publicado: (2017)

Statin Therapy for Primary Prevention of Atrial Fibrillation: Guided by CHADS(2)/CHA(2)DS(2)VASc Score
por: Hung, Chen-Ying, et al.
Publicado: (2014)

Assessment of CHADS(2) and CHA(2)DS(2)-VASc scores in obstructive sleep apnea patients with atrial fibrillation
por: Szymanski, Filip M., et al.
Publicado: (2014)

What should the C (‘congestive heart failure’) represent in the CHA(2)DS(2)‐VASc score?
por: Mulder, Bart A., et al.
Publicado: (2020)

CHA(2)DS(2)‐VASc Score and the Risk of Ventricular Tachyarrhythmic Events and Mortality in MADIT‐CRT
por: Nof, Eyal, et al.
Publicado: (2019)

Predictive Value of CHA(2)DS(2) -VASc-HSF Score for Severity of Acute Coronary Syndrome
por: Liu, Jingyi, et al.
Publicado: (2022)

CHA(2)DS(2)-VASc score for in-hospital recurrence risk stratification in patients with myocardial infarction
por: Pang, Hui, et al.
Publicado: (2022)

Use of the CHA(2)DS(2)VASc score to reduce utilisation of transoesophageal echocardiography prior to ablation for atrial fibrillation
por: Atkinson, Charlotte, et al.
Publicado: (2017)

Can men with atrial fibrillation really rest easy with a CHA(2)DS(2)-VASc score of 0?
por: Cheng, Chen-Di, et al.
Publicado: (2019)

CHA(2)DS(2)-VASc score, cerebral small vessel disease, and frailty in older patients with atrial fibrillation
por: Choi, Jung-Yeon, et al.
Publicado: (2020)

Impact of timing of atrial fibrillation, CHA(2)DS(2)-VASc score and cancer therapeutics on mortality in oncology patients
por: Hussain, Muzna, et al.
Publicado: (2020)

Stroke and Systemic Thromboembolism according to CHA(2)DS(2)-VASc Score in Contemporary Korean Patients with Atrial Fibrillation
por: Lee, Kyung Bae, et al.
Publicado: (2022)

CHA(2)DS(2)-VASc score as a prognostic indicator in patients with atrial fibrillation undergoing coronary stenting
por: ZHENG, Jian-Yong, et al.
Publicado: (2022)

The impact of cigarette smoking in predicting stroke using CHADS(2) and CHA(2)DS(2)-VASc schemas
por: Zuo, Ming-Liang, et al.
Publicado: (2020)

Arterial Thromboembolism in Patients With AF and CHA(2)DS(2)-VASc Score 0-2 With and Without Cancer
por: Leader, Avi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_63pcl7ednpbn5rm9hq3kuftv87